Blood-based biomarker may redefine future treatment for advanced melanoma

byElsevierCirculating tumor DNA (ctDNA) correlates with radiology disease assessment and patient outcome. For patient A, biomarkers in their blood decreased over time and the radiology showed th

Updated on: January 05,2024 13

Blood-based biomarker may redefine future treatment for advanced melanoma

byElsevierCirculating tumor DNA (ctDNA) correlates with radiology disease assessment and patient outcome. For patient A, biomarkers in their blood decreased over time and the radiology showed th

Updated on:January 05,2024 13

Peripheral blood haplo-SCT feasible for leukemia patients 70 years and older

by Elana GotkineFor patients with acute myeloid leukemia (AML)/myelodysplastic syndromes (MDS) aged 70 years and older, haploidentical stem cell transplantation (Haplo-SCT) using a nonmyeloablative co

Updated on: December 28,2023 15

Peripheral blood haplo-SCT feasible for leukemia patients 70 years and older

by Elana GotkineFor patients with acute myeloid leukemia (AML)/myelodysplastic syndromes (MDS) aged 70 years and older, haploidentical stem cell transplantation (Haplo-SCT) using a nonmyeloablative co

Updated on:December 28,2023 15

Not all patients want faster cancer drug approvals without certainty they work

byLondon School of EconomicsCredit: Pixabay/CC0 Public DomainPatients with cancer could be willing to wait for greater certainty of the benefit of new cancer drugs before they are approved by th

Updated on: November 29,2024 0

Not all patients want faster cancer drug approvals without certainty they work

byLondon School of EconomicsCredit: Pixabay/CC0 Public DomainPatients with cancer could be willing to wait for greater certainty of the benefit of new cancer drugs before they are approved by th

Updated on:November 29,2024 0

Great oaks grow from small acorns: Oncology is committed to doing its part for sustainability

byEuropean Society for Medical OncologySustainability will be at the heart of many discussions at theESMO Congress 2022, as illustrated by the new results and initiatives spanning cancer p

Updated on: January 08,2024 10

Great oaks grow from small acorns: Oncology is committed to doing its part for sustainability

byEuropean Society for Medical OncologySustainability will be at the heart of many discussions at theESMO Congress 2022, as illustrated by the new results and initiatives spanning cancer p

Updated on:January 08,2024 10

Even moderate exercise linked to reduced mortality after breast cancer

by Elana GotkineEven moderate physical activity is associated with a reduced risk for mortality for breast cancer survivors, according to a study published online Nov. 17 inJAMA Network Open.Lie

Updated on: December 25,2023 10

Even moderate exercise linked to reduced mortality after breast cancer

by Elana GotkineEven moderate physical activity is associated with a reduced risk for mortality for breast cancer survivors, according to a study published online Nov. 17 inJAMA Network Open.Lie

Updated on:December 25,2023 10

Lung cancer study finds new target for treatment resistance after EGFR inhibitors

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainResearchers at The University of Texas MD Anderson Cancer Center have identified CD70 as being highly expressed

Updated on: December 22,2023 10

Lung cancer study finds new target for treatment resistance after EGFR inhibitors

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainResearchers at The University of Texas MD Anderson Cancer Center have identified CD70 as being highly expressed

Updated on:December 22,2023 10

Disorderly DNA helps cancer cells evade treatment

byNorthwestern UniversityWhen the chromatin packing is heterogenous and disordered, a cell demonstrates more plasticity. Credit: Northwestern UniversityEach cell in the human body holds a full t

Updated on: December 22,2023 10

Disorderly DNA helps cancer cells evade treatment

byNorthwestern UniversityWhen the chromatin packing is heterogenous and disordered, a cell demonstrates more plasticity. Credit: Northwestern UniversityEach cell in the human body holds a full t

Updated on:December 22,2023 10

Adjuvant nivolumab + ipilimumab lacks efficacy for localized renal cell carcinoma

Disease-free survival (DFS) does not differ with adjuvant nivolumab plus ipilimumab (NIVO+IPI) compared with placebo in patients with localized renal cell carcinoma (RCC) at high risk for postnephrect

Updated on: December 22,2023 10

Adjuvant nivolumab + ipilimumab lacks efficacy for localized renal cell carcinoma

Disease-free survival (DFS) does not differ with adjuvant nivolumab plus ipilimumab (NIVO+IPI) compared with placebo in patients with localized renal cell carcinoma (RCC) at high risk for postnephrect

Updated on:December 22,2023 10

Combining immunotherapy with KRAS inhibitor eliminates advanced KRAS-mutant pancreatic cancer in preclinical models

by University of Texas M. D. Anderson Cancer CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainResearchers at The University of Texa

Updated on: January 30,2024 17

Combining immunotherapy with KRAS inhibitor eliminates advanced KRAS-mutant pancreatic cancer in preclinical models

by University of Texas M. D. Anderson Cancer CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainResearchers at The University of Texa

Updated on:January 30,2024 17

Study unveils the role of gamma-delta T cells in cancer immunology

byH. Lee Moffitt Cancer Center & Research InstituteComprehensive pan-cancer analysis of γδ TCRs. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2024.101764A new study pu

Updated on: October 26,2024 0

Study unveils the role of gamma-delta T cells in cancer immunology

byH. Lee Moffitt Cancer Center & Research InstituteComprehensive pan-cancer analysis of γδ TCRs. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2024.101764A new study pu

Updated on:October 26,2024 0

Cancer patients who don't respond to immunotherapy may lack crucial immune cells

byWashington University School of MedicineCD5+ DC frequency was reduced in tumor-affected lymph nodes, and their presence correlated with greater patient survival in multiple tumors. CD5+D

Updated on: December 20,2023 12

Cancer patients who don't respond to immunotherapy may lack crucial immune cells

byWashington University School of MedicineCD5+ DC frequency was reduced in tumor-affected lymph nodes, and their presence correlated with greater patient survival in multiple tumors. CD5+D

Updated on:December 20,2023 12

Scientists discover a new way to prevent secondary breast cancer

byInstitute of Cancer ResearchCredit: Pixabay/CC0 Public DomainScientists have discovered why breast cancer cells that have spread to the lungs may "wake up" following years of sleep,

Updated on: December 27,2023 12

Scientists discover a new way to prevent secondary breast cancer

byInstitute of Cancer ResearchCredit: Pixabay/CC0 Public DomainScientists have discovered why breast cancer cells that have spread to the lungs may "wake up" following years of sleep,

Updated on:December 27,2023 12